TNFRSF11A Polyclonal Antibody

The TNFRSF11A Polyclonal Antibody is applicable for the following applications: ELISA, WB, IF. Host: Rabbit. Species Reactivity: Human (Homo sapiens) . Immunogen: Recombinant Human Tumor necrosis factor receptor superfamily member 11A protein (28-202AA) . Accession Number: Q9Y6Q6. Target Synonyms: CD 265; CD265; FEO; LOH18CR1; Loss of heterozygosity 18 chromosomal region 1; mRANK; ODFR; OFE; OPTB7; Osteoclast differentiation factor receptor; OSTS; Paget disease of bone 2; PDB 2; PDB2; RANK; Receptor activator of NF KB; Receptor activator of NF-KB; receptor activator of nuclear factor kappa B; TNF receptor superfamily member 11a; TNFRSF11A; TNR11_HUMAN; TRANCER; Tumor necrosis factor receptor superfamily member 11a NFKB activator; Tumor necrosis factor receptor superfamily member 11a activator of NFKB; Tumor necrosis factor receptor superfamily member 11A. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Product Specifications

Short Description

The TNFRSF11A Polyclonal Antibody is applicable for the following applications: ELISA, WB, IF.

Accession Number

Q9Y6Q6

Host

Rabbit

Reactivity

Human (Homo sapiens)

Immunogen

Recombinant Human Tumor necrosis factor receptor superfamily member 11A protein (28-202AA)

Target

TNFRSF11A

Clonality

Polyclonal

Conjugation

Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.

Applications

ELISA, WB, IF

Field of Research

Immunology

Purification

>95%, Protein G purified

Concentration

Lot specific. Please inquire or refer to the datasheet included in the product pouch.

Buffer

0.03% Proclin 300, 50% glycerol, 0.01M PBS, pH 7.4

Shipping Conditions

Ice packs

Storage Conditions

2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

Appearance

Liquid

Fragment

IgG

Target Alternative Name

CD 265; CD265; FEO; LOH18CR1; Loss of heterozygosity 18 chromosomal region 1; mRANK; ODFR; OFE; OPTB7; Osteoclast differentiation factor receptor; OSTS; Paget disease of bone 2; PDB 2; PDB2; RANK; Receptor activator of NF KB; Receptor activator of NF-KB; receptor activator of nuclear factor kappa B; TNF receptor superfamily member 11a; TNFRSF11A; TNR11_HUMAN; TRANCER; Tumor necrosis factor receptor superfamily member 11a NFKB activator; Tumor necrosis factor receptor superfamily member 11a activator of NFKB; Tumor necrosis factor receptor superfamily member 11A